Long‐Term Impact of Acyclovir Suppressive Therapy on Genital and Plasma HIV RNA in Tanzanian Women: A Randomized Controlled Trial | Zendy

Clare Tanton | Zendy; Helen A. Weiss | Zendy; Mary Rusizoka | Zendy; Jérôme LeGoff | Zendy; John Changalucha | Zendy; Kathy Baisley | Zendy; Kokugonza Mugeye | Zendy; Dean Everett | Zendy; Laurent Bélec | Zendy; Tim Clayton | Zendy; David A. Ross | Zendy; Richard Hayes | Zendy; Deborah WatsonJones | Zendy

Open Access

Long‐Term Impact of Acyclovir Suppressive Therapy on Genital and Plasma HIV RNA in Tanzanian Women: A Randomized Controlled Trial

Author(s) -

Clare Tanton,

Helen A. Weiss,

Mary Rusizoka,

Jérôme LeGoff,

John Changalucha,

Kathy Baisley,

Kokugonza Mugeye,

Dean Everett,

Laurent Bélec,

Tim Clayton,

David A. Ross,

Richard Hayes,

Deborah WatsonJones

Publication year - 2010

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/651696

Subject(s) - randomized controlled trial , virology , medicine , herpes simplex virus , human immunodeficiency virus (hiv) , sex organ , lentivirus , immunology , virus , sida , viral disease , biology , genetics

Herpes simplex virus (HSV) suppressive therapy reduces genital and plasma human immunodeficiency virus type 1 (HIV-1) RNA over periods up to 3 months, but the long-term effect is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research